
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
Elizabeth Thiele, MD, PhD, pediatric neurologist/epileptologist, discusses symptoms of tuberous sclerosis complex and the role early detection plays in disease prognosis.
Elizabeth Thiele, MD, PhD, pediatric neurologist/epileptologist, discusses symptoms of tuberous sclerosis complex and the role early detection plays in disease prognosis.






